Christian Dior SE (EPA:CDI)
France · Delayed Price · Currency is EUR 440.60
-2.20 (-0.50%)
Aug 5, 2025, 5:35 PM CET
Marinus Pharmaceuticals Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 4,556 | 5,208 | 6,304 | 5,797 | 4,946 | 1,933 | Upgrade |
Depreciation & Amortization | 6,009 | 6,148 | 5,578 | 5,337 | 4,734 | 4,428 | Upgrade |
Other Amortization | 776 | 511 | 454 | 425 | 372 | 329 | Upgrade |
Asset Writedown & Restructuring Costs | 22 | 42 | -15 | 9 | 7 | 4 | Upgrade |
Loss (Gain) on Equity Investments | 11 | 29 | 42 | 26 | 41 | 64 | Upgrade |
Other Operating Activities | 8,544 | 8,906 | 10,611 | 9,255 | 8,110 | 4,484 | Upgrade |
Change in Accounts Receivable | 93 | 137 | -695 | -394 | -613 | 528 | Upgrade |
Change in Inventory | -557 | -1,114 | -4,230 | -4,169 | -1,567 | -562 | Upgrade |
Change in Accounts Payable | -199 | -664 | 434 | 1,532 | 1,576 | -560 | Upgrade |
Change in Other Net Operating Assets | 260 | -284 | -86 | 12 | 1,030 | 225 | Upgrade |
Operating Cash Flow | 19,515 | 18,919 | 18,397 | 17,830 | 18,636 | 10,873 | Upgrade |
Operating Cash Flow Growth | 3.10% | 2.84% | 3.18% | -4.32% | 71.40% | -7.21% | Upgrade |
Capital Expenditures | -5,130 | -5,531 | -7,478 | -4,969 | -2,664 | -2,478 | Upgrade |
Sale of Property, Plant & Equipment | -18 | - | - | - | - | - | Upgrade |
Cash Acquisitions | -38 | -438 | -721 | -809 | -13,226 | -536 | Upgrade |
Divestitures | 21 | - | - | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | 26 | - | - | - | - | - | Upgrade |
Investment in Securities | -655 | -579 | -116 | -149 | -99 | 63 | Upgrade |
Other Investing Activities | -33 | 9 | 5 | 7 | 10 | 12 | Upgrade |
Investing Cash Flow | -5,827 | -6,539 | -8,310 | -5,920 | -15,979 | -2,939 | Upgrade |
Long-Term Debt Issued | - | 3,595 | 5,990 | 3,774 | 251 | 17,499 | Upgrade |
Total Debt Issued | 2,327 | 3,595 | 5,990 | 3,774 | 251 | 17,499 | Upgrade |
Long-Term Debt Repaid | - | -6,591 | -6,786 | -6,642 | -9,216 | -7,326 | Upgrade |
Total Debt Repaid | -6,160 | -6,591 | -6,786 | -6,642 | -9,216 | -7,326 | Upgrade |
Net Debt Issued (Repaid) | -3,833 | -2,996 | -796 | -2,868 | -8,965 | 10,173 | Upgrade |
Common Dividends Paid | -2,346 | -2,346 | -2,255 | -2,165 | -1,264 | -830 | Upgrade |
Other Financing Activities | -6,269 | -5,386 | -6,485 | -7,462 | -5,209 | -1,910 | Upgrade |
Financing Cash Flow | -12,448 | -10,728 | -9,536 | -12,495 | -15,438 | 7,433 | Upgrade |
Foreign Exchange Rate Adjustments | -55 | 80 | -273 | 55 | 498 | -1,052 | Upgrade |
Miscellaneous Cash Flow Adjustments | -1 | 1 | - | - | - | - | Upgrade |
Net Cash Flow | 1,184 | 1,733 | 278 | -530 | -12,283 | 14,315 | Upgrade |
Free Cash Flow | 14,385 | 13,388 | 10,919 | 12,861 | 15,972 | 8,395 | Upgrade |
Free Cash Flow Growth | 12.66% | 22.61% | -15.10% | -19.48% | 90.26% | -0.34% | Upgrade |
Free Cash Flow Margin | 17.37% | 15.81% | 12.67% | 16.24% | 24.87% | 18.80% | Upgrade |
Free Cash Flow Per Share | 79.73 | 74.21 | 60.52 | 71.29 | 88.53 | 46.53 | Upgrade |
Cash Interest Paid | 522 | 483 | 356 | 240 | 231 | 290 | Upgrade |
Cash Income Tax Paid | 5,288 | 5,825 | 6,150 | 5,959 | 4,465 | 2,527 | Upgrade |
Levered Free Cash Flow | 13,133 | 11,259 | 8,728 | 10,672 | 13,340 | 7,811 | Upgrade |
Unlevered Free Cash Flow | 13,898 | 12,001 | 9,337 | 10,911 | 13,491 | 8,041 | Upgrade |
Change in Net Working Capital | -1,098 | 1,295 | 3,503 | 3,130 | -230 | -524 | Upgrade |
Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.